Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pouria Momayyezi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Protocols|November 28, 2022
Small Interfering RNA Delivery Into Primary Human Natural Killer Cells for Functional Gene AnalysesPouria Momayyezi, Karl-Johan Malmberg, Quirin Hammer
European Journal of Immunology|August 1, 2023
Viral escape from NK-cell-mediated immunosurveillance: A lesson for cancer immunotherapy?Pouria Momayyezi, Eleni Bilev, Hans-Gustaf Ljunggren, et al.
European Journal of Immunology|April 13, 2022
An optimized platform for efficient siRNA delivery into human NK cellsDaniel Palacios, Pouria Momayyezi, Oisín Huhn, et al.
Plos Pathogens|December 9, 2024
Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitnessEleni Bilev, Nicole Wild, Pouria Momayyezi, et al.
Genes and Immunity|November 2, 2024
The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19Benedikt Strunz, Pouria Momayyezi, Eleni Bilev, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Genetic ablation of adhesion ligands averts rejection of allogeneic immune cellsQuirin Hammer, Karlo Perica, Hanna van Ooijen, et al.
Cell Stem Cell|July 9, 2024
Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapiesQuirin Hammer, Karlo Perica, Rina M Mbofung, et al.
Cell Reports|March 2, 2022
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cellsQuirin Hammer, Josefine Dunst, Wanda Christ, et al.
Journal for Immunotherapy of Cancer|November 1, 2022
Adaptive single-KIR<sup>+</sup>NKG2C<sup>+</sup> NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemiaAlvaro Haroun-Izquierdo, Marianna Vincenti, Herman Netskar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Protocols|November 28, 2022
Small Interfering RNA Delivery Into Primary Human Natural Killer Cells for Functional Gene AnalysesPouria Momayyezi, Karl-Johan Malmberg, Quirin Hammer
European Journal of Immunology|August 1, 2023
Viral escape from NK-cell-mediated immunosurveillance: A lesson for cancer immunotherapy?Pouria Momayyezi, Eleni Bilev, Hans-Gustaf Ljunggren, et al.
European Journal of Immunology|April 13, 2022
An optimized platform for efficient siRNA delivery into human NK cellsDaniel Palacios, Pouria Momayyezi, Oisín Huhn, et al.
Plos Pathogens|December 9, 2024
Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitnessEleni Bilev, Nicole Wild, Pouria Momayyezi, et al.
Genes and Immunity|November 2, 2024
The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19Benedikt Strunz, Pouria Momayyezi, Eleni Bilev, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Genetic ablation of adhesion ligands averts rejection of allogeneic immune cellsQuirin Hammer, Karlo Perica, Hanna van Ooijen, et al.
Cell Stem Cell|July 9, 2024
Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapiesQuirin Hammer, Karlo Perica, Rina M Mbofung, et al.
Cell Reports|March 2, 2022
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cellsQuirin Hammer, Josefine Dunst, Wanda Christ, et al.
Journal for Immunotherapy of Cancer|November 1, 2022
Adaptive single-KIR<sup>+</sup>NKG2C<sup>+</sup> NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemiaAlvaro Haroun-Izquierdo, Marianna Vincenti, Herman Netskar, et al.
Pageof 1